Transthyretin clinical trials at UC Irvine

• Open-Label Extension Assessing Long Term Safety and Efficacy of IONIS-TTR Rx in Familial Amyloid Polyneuropathy (FAP)

  Sorry, in progress, not accepting new patients

  This study evaluates the safety and tolerability of extended dosing with IONIS-TTR Rx in patients with Familial Amyloid Polyneuropathy.

  Orange, California and other locations

Last updated: November 3, 2020